share_log

Moderna | 4: Statement of changes in beneficial ownership of securities-Director AFEYAN NOUBAR

SEC announcement ·  Jun 12 07:03
Summary by Futu AI
Noubar Afeyan, associated with Moderna, Inc. [MRNA], engaged in a series of stock transactions on June 11, 2024. Afeyan sold a total of 202,832 shares of Moderna's common stock through indirect ownership by Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. The sales were executed at prices ranging from $148.2944 to $149.4038, resulting in a total market value of approximately $30,087,338.87. Following these transactions, Afeyan's indirectly held shares in Moderna amounted to 3,924. The sales are reported to be in progress.
Noubar Afeyan, associated with Moderna, Inc. [MRNA], engaged in a series of stock transactions on June 11, 2024. Afeyan sold a total of 202,832 shares of Moderna's common stock through indirect ownership by Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. The sales were executed at prices ranging from $148.2944 to $149.4038, resulting in a total market value of approximately $30,087,338.87. Following these transactions, Afeyan's indirectly held shares in Moderna amounted to 3,924. The sales are reported to be in progress.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.